Armistice Capital’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMYT
Armistice Capital's AMYT Position: Q1 2023 in Review
Armistice Capital sold out of Amryt Pharma (AMYT) in Q1 2023, closing a stake of 978,000 shares — an estimated $7.14M sold.
Armistice Capital first reported a position in AMYT in Q3 2020 and held it in 10 quarters. The position peaked at $8.8M in Q3 2022. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.
- Armistice Capital reported no remaining Amryt Pharma position as of Q1 2023 after selling out during the quarter.
- Armistice Capital sold 978,000 Amryt Pharma shares in Q1 2023, an estimated $7.14M.
- Armistice Capital first reported a position in Amryt Pharma in Q3 2020 and held it in 10 quarters.
- Armistice Capital's Amryt Pharma position peaked at $8.8M in Q3 2022.
- 79 funds tracked by Wall St. Rank held Amryt Pharma as of Q1 2023.
Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.